Correspondence 0001213900-24-105680 from CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CERO THERAPEUTICS HOLDINGS, INC.
Date: Dec. 4, 2024 · CIK: 0001870404 · Accession: 0001213900-24-105680
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283492
Letter
VIA EDGAR Division of Corporation Finance Office of Life Sciences Acceleration Request for Registration Statement on Form S-1 File No. 333-283492 Requested Date: December 5, 2024 Requested Time: 4:30 p.m. Eastern Time
Dear Ladies and Gentlemen,
Pursuant to Rule 461 under the Securities Act of 1933, as amended, CERo Therapeutics Holdings, Inc. hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to December 5, 2024, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP (“Goodwin”), request by telephone that such Registration Statement be declared effective at some other time.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin, by calling Jeffrey Letalien at (212) 459-7203. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin, Attention: Jeffrey Letalien, by email at JLetalien@goodwinlaw.com.
If you have any questions regarding this request, please contact Jeffrey Letalien of Goodwin at (212) 459-7203.
Sincerely,
CERo Therapeutics Holdings, Inc.
Show Raw Text
CORRESP
1
filename1.htm
CERo
Therapeutics Holdings, Inc.
201
Haskins Way, Suite 230
South
San Francisco, CA 94080
December
4, 2024
VIA
EDGAR
Division
of Corporation Finance
Office
of Life Sciences
U.S.
Securities and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Re: CERo
Therapeutics Holdings, Inc.
Acceleration
Request for Registration Statement on Form S-1
File
No. 333-283492
Requested
Date: December 5, 2024
Requested
Time: 4:30 p.m. Eastern Time
Dear
Ladies and Gentlemen,
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, CERo Therapeutics Holdings, Inc. hereby requests that the effective date of
the above-referenced registration statement (the “Registration Statement”) be accelerated to December 5, 2024, at
4:30 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP (“Goodwin”),
request by telephone that such Registration Statement be declared effective at some other time.
Once
the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin, by calling Jeffrey Letalien at (212)
459-7203. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective
time and date of the Registration Statement be sent to our counsel, Goodwin, Attention: Jeffrey Letalien, by email at JLetalien@goodwinlaw.com.
If
you have any questions regarding this request, please contact Jeffrey Letalien of Goodwin at (212) 459-7203.
Sincerely,
CERo Therapeutics Holdings, Inc.
/s/ Chris
Ehrlich
Chief Executive Officer
cc:
Stephen M. Davis, Esq., Goodwin
Procter LLP
Jeffrey A. Letalien, Esq.,
Goodwin Procter LLP